Skip to main content
Premium Trial:

Request an Annual Quote

Swift Biosciences, Genomenon to Co-Market NGS Panel Design Service

NEW YORK (GenomeWeb) – Swift Biosciences and Genomenon said today that they have entered a new partnership in which they will co-market a service for the design and creation of targeted gene sequencing panels.

In the companies' new combined service, Genomenon will use its automated machine learning approach and Mastermind Genomic Search Engine to identify biomarker targets associated with diseases, producing a list of candidate biomarkers. It will then curate these biomarkers based on the strength and quality of the scientific evidence found in the literature, delivering a final prioritized set.

Swift's role is then to build and validate Accel-Amplicon Custom NGS Panels for the targets in question. The company's technology combines a two-hour, single-tube workflow with highly multiplexed, targeted PCR libraries that are compatible with both Illumina and Ion Torrent sequencing platforms, as well as with most sample types, including limited or degraded samples such as FFPE and cell-free DNA.

Financial and other details of the collaboration were not disclosed.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.